NM_007360.4:c.214A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007360.4(KLRK1):​c.214A>G​(p.Thr72Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.802 in 1,610,626 control chromosomes in the GnomAD database, including 520,524 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.75 ( 43298 hom., cov: 31)
Exomes 𝑓: 0.81 ( 477226 hom. )

Consequence

KLRK1
NM_007360.4 missense

Scores

16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.60

Publications

73 publications found
Variant links:
Genes affected
KLRK1 (HGNC:18788): (killer cell lectin like receptor K1) Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The NKG2 gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed in NK cells. This gene encodes a member of the NKG2 family. The encoded transmembrane protein is characterized by a type II membrane orientation (has an extracellular C terminus) and the presence of a C-type lectin domain. It binds to a diverse family of ligands that include MHC class I chain-related A and B proteins and UL-16 binding proteins, where ligand-receptor interactions can result in the activation of NK and T cells. The surface expression of these ligands is important for the recognition of stressed cells by the immune system, and thus this protein and its ligands are therapeutic targets for the treatment of immune diseases and cancers. Read-through transcription exists between this gene and the upstream KLRC4 (killer cell lectin-like receptor subfamily C, member 4) family member in the same cluster. [provided by RefSeq, Dec 2010]
KLRC4-KLRK1 (HGNC:48357): (KLRC4-KLRK1 readthrough) This locus represents naturally occurring read-through transcription between the neighboring KLRC4 (killer cell lectin-like receptor subfamily C, member 4) and KLRK1 (killer cell lectin-like receptor subfamily K, member 1) genes on chromosome 12. The read-through transcript includes an alternate 5' exon and lacks a significant portion of the KLRC4 coding sequence, including the start codon, and it thus encodes the KLRK1 protein. [provided by RefSeq, Dec 2010]
KLRK1-AS1 (HGNC:54868): (KLRK1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0851428E-6).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.862 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLRK1NM_007360.4 linkc.214A>G p.Thr72Ala missense_variant Exon 4 of 8 ENST00000240618.11 NP_031386.2 P26718-1A0A024RAP8
KLRC4-KLRK1NM_001199805.1 linkc.214A>G p.Thr72Ala missense_variant Exon 9 of 13 NP_001186734.1 P26718-1A0A024RAP8
KLRK1-AS1NR_120430.1 linkn.393T>C non_coding_transcript_exon_variant Exon 3 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLRK1ENST00000240618.11 linkc.214A>G p.Thr72Ala missense_variant Exon 4 of 8 1 NM_007360.4 ENSP00000240618.6 P26718-1
KLRC4-KLRK1ENST00000539300.5 linkn.*411A>G non_coding_transcript_exon_variant Exon 9 of 13 2 ENSP00000455951.1 H3BQV0
KLRC4-KLRK1ENST00000539300.5 linkn.*411A>G 3_prime_UTR_variant Exon 9 of 13 2 ENSP00000455951.1 H3BQV0

Frequencies

GnomAD3 genomes
AF:
0.747
AC:
113519
AN:
151912
Hom.:
43277
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.577
Gnomad AMI
AF:
0.747
Gnomad AMR
AF:
0.828
Gnomad ASJ
AF:
0.796
Gnomad EAS
AF:
0.773
Gnomad SAS
AF:
0.884
Gnomad FIN
AF:
0.810
Gnomad MID
AF:
0.769
Gnomad NFE
AF:
0.808
Gnomad OTH
AF:
0.760
GnomAD2 exomes
AF:
0.808
AC:
201579
AN:
249454
AF XY:
0.812
show subpopulations
Gnomad AFR exome
AF:
0.576
Gnomad AMR exome
AF:
0.888
Gnomad ASJ exome
AF:
0.788
Gnomad EAS exome
AF:
0.759
Gnomad FIN exome
AF:
0.810
Gnomad NFE exome
AF:
0.806
Gnomad OTH exome
AF:
0.801
GnomAD4 exome
AF:
0.807
AC:
1177745
AN:
1458596
Hom.:
477226
Cov.:
45
AF XY:
0.810
AC XY:
587957
AN XY:
725450
show subpopulations
African (AFR)
AF:
0.570
AC:
19031
AN:
33392
American (AMR)
AF:
0.882
AC:
39219
AN:
44472
Ashkenazi Jewish (ASJ)
AF:
0.789
AC:
20560
AN:
26046
East Asian (EAS)
AF:
0.789
AC:
31186
AN:
39538
South Asian (SAS)
AF:
0.880
AC:
75175
AN:
85430
European-Finnish (FIN)
AF:
0.809
AC:
43120
AN:
53306
Middle Eastern (MID)
AF:
0.788
AC:
4520
AN:
5734
European-Non Finnish (NFE)
AF:
0.808
AC:
897503
AN:
1110418
Other (OTH)
AF:
0.787
AC:
47431
AN:
60260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
10615
21230
31844
42459
53074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20830
41660
62490
83320
104150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.747
AC:
113585
AN:
152030
Hom.:
43298
Cov.:
31
AF XY:
0.749
AC XY:
55700
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.577
AC:
23910
AN:
41428
American (AMR)
AF:
0.828
AC:
12645
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.796
AC:
2760
AN:
3468
East Asian (EAS)
AF:
0.774
AC:
4007
AN:
5180
South Asian (SAS)
AF:
0.884
AC:
4258
AN:
4818
European-Finnish (FIN)
AF:
0.810
AC:
8554
AN:
10564
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.808
AC:
54933
AN:
67982
Other (OTH)
AF:
0.763
AC:
1609
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1360
2720
4080
5440
6800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.786
Hom.:
182736
Bravo
AF:
0.738
TwinsUK
AF:
0.807
AC:
2994
ALSPAC
AF:
0.799
AC:
3080
ESP6500AA
AF:
0.579
AC:
2552
ESP6500EA
AF:
0.800
AC:
6877
ExAC
AF:
0.803
AC:
97496
Asia WGS
AF:
0.816
AC:
2836
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.87
T
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.3
DANN
Benign
0.91
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0069
N
LIST_S2
Benign
0.30
.;T
MetaRNN
Benign
0.0000011
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
-1.6
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.60
N;N
REVEL
Benign
0.010
Sift
Benign
0.96
T;T
Sift4G
Benign
0.27
T;T
Vest4
0.044
MPC
0.18
ClinPred
0.00087
T
GERP RS
-1.4
gMVP
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2255336; hg19: chr12-10532326; COSMIC: COSV53698409; COSMIC: COSV53698409; API